Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-09

FDA Approved: TAVABOROLE — Original Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved Cipla USA Inc.'s original generic application for tavaborole, enabling a generic version of tavaborole topical solution for onychomycosis (nail…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tavaborole (Tavaborole)

Snippet

ORIG AP for TAVABOROLE (TAVABOROLE)